TACE for HCC in patients with serum albumin ≤ 3.8 g/dL, PT ≤ 80%, and largest tumor diameter ≥ 3.8 cm is likely to cause deterioration of the Child‐Pugh classification, leading to delayed introduction of systemic therapy. The gene discussed is ALB; the disease is neoplasm.